Patient info Search Menu

Buprenorphine 0.4 mg sublingual tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM) Controlled drug (Schedule 3)
Medicine strength:
0.4 mg
Contains active substance:

Patient leaflet - Buprenorphine 0.4 mg sublingual tablets

1. What Buprenorphine tablets are and what they are used for

Buprenorphine is used to treat dependence on opiate (narcotic) drugs, such as morphine and heroin in drug addicts who have agreed to be treated for their addiction.

Buprenorphine sublingual tablets is used in adults and adolescents over 16 years of age who are also receiving medical, social and psychological support.

It contains buprenorphine which belongs to a class of medicines called opioids, which are ‘pain relievers.

This medicine has been prescribed to you and should not be given to anyone else.

Opioids can cause addiction and you may get withdrawal symptoms if you stop taking it suddenly. Your prescriber should have explained how long you will be taking it for and when it is appropriate to stop, how to do this safely.

2. What you need to know before you take Buprenorphine tablets

Do not take Buprenorphine tablets

  • If you are a child under the age of 16 years.
  • If you are allergic (hypersensitive) to buprenorphine or to any

    of the other ingredients of this

    medicine (listed in section 6).

  • If you have serious breathing problems.
  • If you have serious problems with your liver.
  • If you are intoxicated due to alcohol or have trembling,

    sweating, anxiety confusion or hallucinations

    caused by alcohol.

  • If you are breast feeding a baby.

  • If you are taking naltrexone or nalmefene for the treatment of

    alcohol or opioid dependence.

Warnings and precautions

Talk to your prescriber before taking this medicine if you:

  • seizures, fits or convulsions
  • asthma or other breathing problems
  • any liver disease such as hepatitis
  • low blood pressure
  • recently suffered head injury or brain disease
  • a urinary disorder (especially linked to enlarged prostate

    in men)

  • any kidney disease
  • thyroid problems
  • adrenocortical disorder (e.g. Addison’s disease)
  • depression or other conditions that are treated with

    antidepressants. The use of these medicines together with Buprenorphine can lead to serotonin syndrome, a potentially life- threatening condition (see ‘’ Other medicines and Buprenorphine tablets’’).

  • are or have ever been addicted to opioids, alcohol,

    prescription medicines, or illegal drugs.

  • have previously suffered from withdrawal symptoms such

    as agitation, anxiety, shaking or sweating, when you have stopped taking alcohol or drugs.

  • feel you need to take more of Buprenorphine Tablets to

    get the same level of pain relief, this may mean you are becoming tolerant to the effects of this medicine or are becoming addicted to it.

    Speak to your prescriber who will discuss your treatment

    and may change your dose or switch you to an alternative

    pain reliever.

Tolerance, dependence, and addiction

This medicine contains buprenorphine which is an opioid medicine. Repeated use of opioids can result

in the drug being less effective (you become accustomed to it, known as tolerance). Repeated use of

Buprenorphine tablets can also lead to dependence, abuse, and addiction, which may result in life

threatening overdose.

Dependence or addiction can make you feel that you are no longer in control of how much medicine you

need to take or how often you need to take it.

The risk of becoming dependent or addicted varies from person to person. You may have a greater risk of becoming dependent on

or addicted to buprenorphine if:

  • You or anyone in your family have ever abused or been

    dependent on alcohol, prescription medicines or illegal drugs (“addiction”).

  • You are a smoker.
  • You have ever had problems with your mood (depression,

    anxiety, or a personality disorder) or have been treated by a psychiatrist for other mental illnesses.

If you notice any of the following signs whilst taking Buprenorphine tablets, it could be a sign that you have become dependent or addicted:

  • You need to take the medicine for longer than advised by

    your doctor

  • You need to take more than the recommended dose
  • You are using the medicine for reasons other than

    prescribed, for instance, ‘to stay calm’ or ‘help you sleep’

  • You have made repeated, unsuccessful attempts to quit

    or control the use of the medicine

  • When you stop taking the medicine you feel unwell, and

    you feel better once taking the medicine again (‘withdrawal effects’)

If you notice any of these signs, speak to your doctor to discuss the best treatment pathway for you, including when it is appropriate to stop and how to stop safely (See section 3, If you stop taking Buprenorphine tablets.

Important things to be aware of:

Misuse, abuse and diversion

This medicine can be a target for people who abuse prescription medicines and should be kept in a safe place to protect it from theft. Opioids should only be used by those they are prescribed for. Do not give this medicine to anyone else. Taking higher doses or more frequent doses of opioid may increase the risk of addiction. Overuse and misuse can lead to overdose and/or death. Breathing problems

Some people have died from respiratory failure (inability to breathe) because they misused this medicine or took it in combination with other central nervous system depressants, such

as alcohol, benzodiazepines (tranquilisers), or other opioids. Addiction and withdrawal symptoms

Taking this medicine regularly, particularly for a long time, can lead

to addiction. Your prescriber should have explained how long you will be taking it for and when it is appropriate to stop, how to do this safely.

Rarely, increasing the dose of this medicine can make you more sensitive to pain. If this happens, you need to speak to your prescriber about your treatment.

Addiction can cause withdrawal symptoms when you stop taking this medicine. Withdrawal symptoms can include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or

Colour Black

Size: 180x600 mm

Note: 2000XXXX Indicates provision for Rusan SAP code

8114170-7803

  • It was not affecting your ability to drive safely Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.

Important information about some of the ingredients of Buprenorphine tablets Buprenorphine tablets contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. Buprenorphine 2 mg and Buprenorphine 8 mg sublingual tablets also contain the colouring agent sunset yellow (E110), which may cause allergic reactions.

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Buprenorphine tablets

You must place the tablet under your tongue (sublingual) and allow it to dissolve which will take 5 to 10 minutes. This is the only way to take the tablets. Do not chew or swallow them whole, as they will not work.

Your prescriber should have discussed with you, how long the course of Buprenorphine tablets will last.

They will arrange a plan for stopping treatment. This will outline how to gradually reduce the dose and

stop taking the medicine.

Your doctor will tell you how many tablets to take and you should always follow this advice.

To avoid sudden withdrawal symptoms, treatment with Buprenorphine tablets should be given when there are already clear signs of withdrawal symptoms.

Your prescriber should discuss your treatment and whether you need to continue taking tablets at regular intervals. If you and your prescriber decide to stop treatment, a plan will be put in place to gradually reduce the dose and stop taking the medicine to minimise the risk of withdrawal effects.

Adults and children over the age of 16 years: when beginning treatment the dose is between 0.8 to 4mg, taken once a day. For drug addicts who have not had any withdrawal treatment: one dose of Buprenorphine tablets should be taken at least 6 hours after the last use of the opioid (narcotic such as morphine or

heroin), or when the first signs of craving appear. If you take it less than six hours after you use a narcotic you may get withdrawal symptoms.

For patients taking methadone: before beginning treatment, your doctor should reduce your dose of methadone to not more than 30mg a day. Buprenorphine tablets may cause withdrawal symptoms in patients who are dependent on methadone if used within 24 hours of the last dose of methadone.

During your treatment, your doctor may increase your dose of Buprenorphine tablets, to a maximum single daily dose of 32mg, depending upon your response. Once you have been stable for a while, your doctor will gradually reduce your dose and it may be possible to stop it altogether. Do not suddenly stop taking the tablets, as this may cause withdrawal symptoms. If you take more Buprenorphine tablets than you should

If you or someone else takes too much of this medicine, you must go or be taken immediately to an emergency centre or hospital as overdose with Buprenorphine tablets may cause serious and life- threatening breathing problems.

If you forget to take Buprenorphine tablets

Tell your doctor as soon as possible if you miss a dose and follow his or her instructions. Do not take a double dose to make up for the forgotten dose.

If you stop taking Buprenorphine tablets

Do not suddenly stop taking this medicine. If you want to stop taking this medicine, discuss this with your prescriber first. They will tell you how to do this, usually by reducing the dose gradually so that any unpleasant withdrawal effects are kept to a minimum. Withdrawal symptoms such as restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating may occur if you suddenly stop taking this medicine.

Pregnancy

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor immediately or seek urgent medical attention if you experience side effects such as:

  • sudden wheezing, difficulty breathing, swelling of the eyelids,

    face, tongue, lips, throat or hands;

    rash or itching especially those covering your whole body.

    These may be signs of a life-threatening

    allergic reaction.

  • if you start to breathe more slowly or weakly than expected

    (respiratory depression).

  • if you start to feel faint, as this may be a sign of low blood

    pressure.

Also tell your doctor immediately if you experience side effects such as:

  • severe fatigue (tiredness), have no appetite or if your skin or

    eyes look yellow. These may be symptoms of liver damage The frequency of possible side effects listed below is defined using the following convention:

    • Very common (may affect more than 1 in 10 people)
    • Common (may affect up to 1 in 10 people)
    • Not known (frequency cannot be estimated from the

      available data).

Side effects reported with Buprenorphine tablets Very common

  • drug withdrawal syndrome
  • headache
  • hyperhidrosis (sweating)
  • insomnia (inability to sleep)
  • nausea (feeling sick)
  • pain

Common

  • Abdominal pain
  • agitation
  • anxiety
  • joint pain
  • weakness
  • back pain
  • bone pain
  • bronchitis
  • chest pain
  • chills
  • constipation
  • cough
  • decreased appetite
  • depression
  • diarrhoea
  • dizziness
  • dry mouth
  • painful period
  • indigestion
  • shortness of breath
  • flatulence
  • gastrointestinal disorder
  • hostility
  • increase in muscle tension
  • infection
  • influenza
  • nervousness
  • tearing (watery eyes) disorder
  • swollen glands (lymph nodes)
  • malaise
  • a general feeling of discomfort
  • migraine
  • muscle spasms
  • muscle pain
  • dilation of the pupil
  • neck pain
  • palpitations
  • paranoia
  • burning or tingling in hands and feet
  • swelling (hands and feet)
  • runny or stuffy nose
  • sore throat and painful swallowing
  • fever

    • rash
    • sleepiness
    • syncope (fainting)
    • thinking abnormal
    • tooth disorder
    • tremor
    • flushing
    • vomiting (being sick)
    • yawning

Not known

  • Dental caries
  • Drug dependence
  • drug withdrawal syndrome in newborn
  • hallucinations (sensing things that are not real)
  • drop in blood pressure on changing position from sitting or lying down to standing
  • difficulty in urinating
  • Misusing this medicine by injecting it can cause withdrawal symptoms, infections, other skin reactions and potentially serious liver problems

Drug Withdrawal

When you stop taking Buprenorphine Tablets, you may experience drug withdrawal symptoms, which include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating. How do I know if I am addicted?

If you notice any of the following signs whilst taking Buprenorphine Tablets, it could be a sign that you have become addicted.

  • You need to take the medicine for longer than advised by your prescriber
  • You feel you need to use more than the recommended dose
  • You are using the medicine for reasons other than prescribed
  • When you stop taking the medicine you feel unwell, and you feel better once taking the medicine again

If you notice any of these signs, it is important you talk to your prescriber

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Buprenorphine tablets

Keep this medicine out of the sight and reach of children. Store this medicine in a safe and secure place, where other people cannot access it. It can cause serious harm and be fatal to people who may take this medicine by accident, or intentionally when it has not been prescribed for them.

Do not use Buprenorphine tablets after the expiry date which is stated on the carton, blister and label after EXP. The expiry date refers to the last day of that month.

Blister packs:

Do not store above 25°C. Store in the original package in order to protect from moisture.

Tablet containers:

Do not store above 30°C. Keep the container tightly closed in order to protect from moisture.

Do not throw away medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information What Buprenorphine tablets contain

  • The active substance is buprenorphine (as buprenorphine hydrochloride). Each tablet contains 0.4, 2 mg or 8 mg of buprenorphine.
  • The other ingredients are magnesium stearate, sodium citrate, povidone, anhydrous citric acid, pregelatinised starch (maize), and lactose monohydrate. Buprenorphine 2 mg and Buprenorphine 8 mg sublingual tablets also contain crospovidone, mannitol and sunset yellow (E110). What Buprenorphine tablets look like and contents of the pack

Buprenorphine 0.4 mg sublingual tablets are uncoated, white or almost white, 6 mm round and flat with “B” on one side. Buprenorphine 2 mg sublingual tablets are uncoated, light orange, 5 × 8 mm oval and biconvex with “B” on one side. Buprenorphine 8 mg sublingual tablets are uncoated, light orange, 7.35 × 13.35 mm oval and biconvex with “B” on one side. Buprenorphine is available in tablet containers and blister packs in pack sizes of 1, 7, 20, 24, 28, 48 and 50 tablets. Not all pack sizes may be marketed

Marketing Authorisation Holder Torrent Pharma (UK) Ltd, 3rd Floor, Nexus Building 4 Gatwick Road

Crawley West Sussex RH10 9BG United Kingdom Manufacturer Actavis hf ., Reykjavíkurvegi 78, IS-220 Hafnarfjörður Iceland

This leaflet was last revised in 09/2026.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 36687/0265

Last revision stated in the text: September 2026 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Buprenorphine 0.4 mg sublingual tablets

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Controlled drug?
Yes, Schedule 3 of the Misuse of Drugs Regulations?
  • Controlled drugs are medicines that UK law controls more strictly because they can be misused or cause dependence. The Misuse of Drugs Regulations 2001 divide them into 5 schedules: schedule 1 has the strictest rules and schedule 5 the least strict.
  • Schedule 3 includes, for example, tramadol, gabapentin, pregabalin and buprenorphine.
  • A prescription is valid for 28 days and usually covers up to 30 days of treatment. In England it cannot be issued as a repeat dispensing prescription.
  • Travelling abroad: carry it in your hand luggage, take your prescription or a letter from your doctor to show it is yours, and check the rules of the country you are going to with its embassy before you travel (GOV.UK).
Active substance? Buprenorphine
Strength? 0.4 mg
Pharmaceutical form? Sublingual tablet
Uncoated, white or almost white, 6 mm round, flat tablets with “B” on one side.
How is it taken? Sublingual
Excipients? Magnesium stearate, Sodium citrate, Povidone, Citric acid, Starch, pregelatinised (maize), Lactose monohydrate, Sunset yellow (E110), Crospovidone, Mannitol
Pack sizes 7 tablet
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? Blister packs (Al/Al and Al/PVC/PVDC): 2 years
Blister packs (Al/PVC/PVDC Perlalux Tristar Ultra): 1 year Tablet containers: 2 years
Storage Blister packs: Do not store above 25°C. Store in the original package in order to protect from moisture.
Tablet containers: Do not store above 25°C. Keep the container tightly closed in order to protect from moisture.
Drug group (ATC)? Oripavine derivatives
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02A Opioid analgesics
        1. N02AE Oripavine derivatives analgesics
          1. N02AE01 buprenorphine
Marketing authorisation? PL 00142/1109 (first authorised 7 September 2011), PL 36687/0265
Marketing authorisation holder? Accord-UK Ltd
Codes? GTIN 5012617001245 · BNF 04070200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.